Publication:
Significance of a clinical pharmacist-led comprehensive medication management program for hospitalized oncology patients

dc.contributor.authorYUMUK, PERRAN FULDEN
dc.contributor.authorRABUŞ, ŞULE
dc.contributor.authorsUmar, Rashida Muhammad; Apikoglu-Rabus, Sule; Yumuk, Perran Fulden
dc.date.accessioned2022-03-12T22:41:28Z
dc.date.accessioned2026-01-11T18:43:41Z
dc.date.available2022-03-12T22:41:28Z
dc.date.issued2020
dc.description.abstractBackground The use of highly toxic drugs in cancer treatment and supportive care medications exposes patients to an increased number of drug-related problems (DRPs). Clinical pharmacists contribute to the optimal use of medications by intervening in identified drug-related problems. Objective To evaluate the relevance of a comprehensive medication management service in oncology patients. Setting Marmara University Teaching and Research Hospital Medical Oncology Ward, Istanbul, Turkey. Methods This prospective study was carried out between December 2015 and April 2016 with adult patients with confirmed malignancy. Comprehensive medication management was performed by the clinical pharmacist throughout the patient's hospital stay. The medication-related data as well as data regarding demographic and general health status of the patients were reviewed for the presence of drug-related problems. The identified problems, interventions and acceptance rate by physicians were recorded with the help of the Pharmaceutical Care Network Europe V6.0 (PCNE) classification. Main outcome measures Number and causes of drug-related problems, nature and acceptance rate of clinical pharmacist interventions and rate of problems solved. Results The study included 137 patients. The mean (SD) age of the patients was 58 (14.6) years. A total of 481 drug-related problems were recorded. The most frequent drug-related problems were 'adverse drug events [including drug interactions]' (n = 376), 'untreated indications' (n = 59) and 'unnecessary drug treatment' (n = 25). Inappropriate combination of drugs was the cause of 73.2% of the total problems. Interventions were made to stop administration of a suitable drug if the combination with another drug was contraindicated while prescribers were mostly informed about major drug interactions. The prescribers approved 93% of the total intervention proposals. The majority (90.9%) of the identified problems were totally solved. Conclusion Integration of clinical pharmacy services through a comprehensive medication management program in oncology will help to reduce the number of drug-related problems.
dc.identifier.doi10.1007/s11096-020-00992-8
dc.identifier.eissn2210-7711
dc.identifier.issn2210-7703
dc.identifier.pubmed32078106
dc.identifier.urihttps://hdl.handle.net/11424/236120
dc.identifier.wosWOS:000516444500004
dc.language.isoeng
dc.publisherSPRINGER
dc.relation.ispartofINTERNATIONAL JOURNAL OF CLINICAL PHARMACY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectClinical pharmacist
dc.subjectDrug-related problems
dc.subjectMedication management
dc.subjectOncology
dc.subjectTurkey
dc.subjectDRUG-DRUG INTERACTIONS
dc.subjectTHERAPY MANAGEMENT
dc.subjectIMPACT
dc.subjectCANCER
dc.subjectCARE
dc.subjectINTERVENTION
dc.subjectRECONCILIATION
dc.subjectDISCREPANCIES
dc.subjectADHERENCE
dc.subjectCOMMUNITY
dc.titleSignificance of a clinical pharmacist-led comprehensive medication management program for hospitalized oncology patients
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage661
oaire.citation.issue2
oaire.citation.startPage652
oaire.citation.titleINTERNATIONAL JOURNAL OF CLINICAL PHARMACY
oaire.citation.volume42

Files